Whole-exome sequencing has indicated the pathophysiological significance of the SLCO2A1 gene in human; loss-of-function mutations in SLCO2A1 are related to primary hypertrophic osteoarthropathy and pachydermoperiostosis (Nakanishi and Tamai, 2017). Here, SLCO2A1 is linked to Pachydermoperiostosis.